CClinicalTrials.gg
CompletedNCT05109715VENTMICSUpdated Oct 21, 2022

The Effect of Mechanical Ventilation on the Occurrence of Myocardial Ischemia: a Pilot Study

An interventional study of Continued ventilation and Discontinued ventilation in Myocardial Ischemia and Hypoxia, sponsored by Jessa Hospital. Completed at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-10-21.

Sponsored by Jessa Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
14
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of the proposed pilot study is to determine which method can detect myocardial ischemia at the predefined timepoints during endo-CABG. Additionally, the investigators want to examine the influence of mechanical ventilation on the occurrence of myocardial ischemia in patients undergoing endo-CABG.

Read the detailed description

CABG is the most effective therapy for patients suffering from coronary artery disease, a condition which annually affects 126 million people worldwide. During this surgery, cardiopulmonary bypass (CPB) takes over the function of the heart and lungs. As a result of the emergence of minimally invasive cardiac surgery (MICS) (e.g. endoscopic-CABG), peripheral CPB with femoral arterial cannulation became the most commonly utilized strategy. However, the use of retrograde arterial perfusion is not without risk. It may result in the upper body and coronary arteries being perfused with deoxygenated blood. The hypoxemia will induce myocardial ischemia and this can harm the cardiac myocytes. A solution for this inconvenience is still lacking. Literature reports that establishing adequate ventilation support should help overcome this phenomenon. However, this approach has not yet been investigated in a clinical trial. In general, this phenomenon is not well recognized in the typical surgical setting, and limited research has been done.

The goal of the proposed pilot study is to determine which method can detect myocardial ischemia at the predefined timepoints during endo-CABG. Additionally, the investigators want to examine the influence of mechanical ventilation on the occurrence of myocardial ischemia in patients undergoing endo-CABG.

02

Conditions studied

  • Myocardial Ischemia
  • Hypoxia

Keywords

  • Cardiac surgery
  • Ventilation
03

In context

Myocardial Ischemia

3,233 studies on the registry are indexed under Myocardial Ischemia; 396 are open to participants now.

This study's enrollment of 14 is below the median of 120 across 1,895 interventional studies indexed under Myocardial Ischemia.

Browse Myocardial Ischemia studies →

Lead sponsor

Jessa Hospital is the lead sponsor of 85 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age > 18 years old
  • Patients undergoing their first elective endo-CABG procedure
  • Patients capable of signing the informed consent
  • Patients able to speak Dutch or French

Exclusion criteria

Exclusion Criteria:

  • Ongoing participation in another trial
  • Ejection fraction \< 50%
  • Lung diseases (COPD, asthma)
  • Use of corticosteroids
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
14 participants (actual)

Study arms

  • Active comparator
    Control group

    Ventilation is discontinued after going on CPB and lungs are exposed to atmospheric pressure. Blood will be drawn: * At baseline: before general anaesthesia * After start of heart-lung machine * After clamping the aorta * Before unclamping the aorta * After the operation * 5 h after clamping the aorta * 12 hours after clamping the aorta * 24 hours after aortic clamping * 48h after clamping the aorta * 72 hours after clamping the aorta

    Procedure: Discontinued ventilation

  • Experimental
    Ventilation group

    Ventilation is continued from going on CPB until clamping of the ascending aorta. Blood will be drawn: * At baseline: before general anaesthesia * After start of heart-lung machine * After clamping the aorta * Before unclamping the aorta * After the operation * 5 h after clamping the aorta * 12 hours after clamping the aorta * 24 hours after aortic clamping * 48h after clamping the aorta * 72 hours after clamping the aorta

    Procedure: Continued ventilation

Interventions

  • ProcedureContinued ventilation

    Ventilation is continued from going on CPB until clamping of the ascending aorta with tidal volume 3ml/kg ideal body weight, Fraction of inspired oxygen (FiO2) 50%, respiratory rate 5/min and Inspiratory:Expiratory (I/E) ratio 1/2.

  • ProcedureDiscontinued ventilation

    Ventilation is discontinued after going on CPB and lungs are exposed to atmospheric pressure

06

What researchers measure

Primary outcomes

  1. The detection of myocardial ischemia using Cardiac Troponin T (cTn-T)

    If the value of Cardiac Troponin T (cTn-T) exceeds 14 ng/L, then cTn-T is able to detect myocardial ischemia at the predefined time points.

    Time frame: Until 72 hours after clamping the aorta

  2. The detection of myocardial ischemia using Heart-type Fatty Acid Binding Protein (hFABP)

    If the value of Heart-type Fatty Acid Binding Protein (hFABP) exceeds 6 ng/L, then hFABP is able to detect myocardial ischemia at the predefined time points.

    Time frame: Until 5 hours after clamping the aorta

  3. The detection of myocardial ischemia using Creatine Kinase Myocardial Band (CK-MB)

    If the value of Creatine Kinase Myocardial Band (CK-MB) exceeds 6.2 µg/L, then CK-MB is able to detect myocardial ischemia at the predefined time points.

    Time frame: Until 48 hours after clamping the aorta

  4. The detection of myocardial ischemia using Reactive Oxygen Species (ROS)

    Reactive Oxygen Species (ROS) measurements include a malondialdehyde assay to assess the lipid peroxidation, an Oxystat test to analyse the total peroxide levels and a protein carbonyl assay to assess the protein damage due to cardiomyocyte dysfunction. Additionally a biopsy will be taken to analyze pro- and anti-oxidants. If a significant increase in lipid peroxidation, total peroxide levels, protein damage and/or pro- and anti-oxidants in the ventilation group compared to the control group is present, then ROS is able to detect myocardial ischemia at the predefined time points.

    Time frame: Until unclamping the aorta (on average until 64 minutes after clamping the aorta)

  5. The occurence of hypoxemia using blood gas measurement

    If the partial pressure of oxygen (PaO2) is lower than 60 mmHg, then hypoxemia is present.

    Time frame: Until the end of surgery (on average until 203 minutes after the start of the surgery)

07

Study locations

1 site
  • Jessa Hospital
    Hasselt, Limburg, Belgium
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 21, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05109715
Lead sponsor
Jessa Hospital
Responsible party
Sponsor
First posted
Nov 5, 2021
Start date
Jan 24, 2022
Primary completion
Apr 18, 2022
Completion
Oct 4, 2022
Last update
Oct 21, 2022

Study contacts

Abdullah Kaya, PhD
principal investigator · Jessa Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion